VRBCF — Virbac SA/ADR

OTC · Unknown · Unknown · CIK 2029969 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
2026-03-17
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific. The company offers Vikaly, a cat food designed for the management of feline chronic kidney disease; Prevexto that contains imidacloprid and flumethrin, providing long-lasting parasite protection collar for dogs and cats at risk of fleas, ticks, lice, and sandflies; Zenidog/Zenifel offers a fogger, spray, and non-electric pheromone gel diffuser to soothe and reduce stress-related behaviors in dogs; Suigen Entero 3 is an inactivated vaccine aimed at preventing neonatal diarrhea in piglets caused by colibacillosis, clostridium, and rotavirus; Ursolyx soft chews formulated with ursolic acid that support muscle strength and mobility in dogs and cats; Zenifel a fogger and spray designed to reduce behaviors due to stress or undesirable behaviors in cats; Suigen PCV2 is a vaccine for porcine circovirus type 2; and Suigen Donoban is a multivalent vaccine used for the prevention of respiratory diseases in swine. It also provides a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, immunology, nutrition, petfood, and pharmaceutical products. In addition, the company serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 1,914,167,000 122,500,000 789,185,000
Jun 2025 1,815,427,000 128,671,000 750,283,000
Dec 2024 1,848,522,000 149,631,000 805,119,000

Balance + Analyst (yfinance extras)

Retained Earnings
$150,887,000
Inventory
$378,791,000
Receivables
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,464,676,992
EBITDA
$278,270,016
Free Cash Flow
$126,753,248
Enterprise Value
$3,581,423,104
Total Cash
$126,160,000
Total Debt
$289,639,008
Shares Out
8,381,624
Trailing EPS
$20.93
Book Value
$146.18
ROE
13.9%
ROA
7.6%
Div Yield
0.42%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,464,677,000 230,148,000 150,887,000 1,914,167,000 789,185,000 198,990,000
Dec 2024 1,397,379,000 228,307,000 145,290,000 1,848,522,000 805,119,000 204,221,000
Dec 2023 1,246,901,000 185,703,000 121,298,000 1,455,730,000 545,813,000 118,641,000
Dec 2022 1,216,187,000 183,472,000 121,943,000 1,333,620,000 494,332,000 98,984,000

Peers — same industry

TickerNameMarket CapLastDaily %
SPY SPDR S&P 500 ETF TRUST $688.88B $750.59
KLAC KLA CORP $262.74B $2011.39
IBM INTERNATIONAL BUSINESS MACHINES CORP $235.62B $250.69
KXIAY Kioxia Holdings Corporation/ADR $231.81B $42.45
SMEGF Siemens Energy AG/ADR $180.38B $212.00

News headlines (Yahoo Finance, 1h cache)

Virbac : Declaration of the number of shares and voting rights 04/2026
2026-05-07 08:11 · Yahoo
A Look At Virbac (ENXTPA:VIRP) Valuation As Shares Ease Despite Longer Term Gains
2026-05-04 22:11 · Yahoo
Leading with Care: Virbac Becomes a Human-Animal Bond Certified Company
2026-04-22 18:40 · Yahoo
Virbac shares jump on Q1 growth as North America surge offsets FX drag
2026-04-17 08:07 · Yahoo
Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms
2026-04-16 15:45 · Yahoo
Virbac : Declaration of the number of shares and voting rights 03/2026
2026-04-07 09:06 · Yahoo
Assessing Virbac (ENXTPA:VIRP) Valuation As Investors Revisit The Stock’s Recent Performance
2026-03-18 20:05 · Yahoo
Virbac: 2025 annual results
2026-03-17 16:45 · Yahoo
Virbac : Declaration of the number of shares and voting rights 02/2026
2026-03-10 17:10 · Yahoo
Virbac : Declaration of the number of shares and voting rights 01/2026
2026-02-05 16:29 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.